ReGen III closes $1.75-million private placement

Executive Summary

• ReGen III Corp. has closed a non-brokered private placement, issuing 8.75 million units at $0.20 per unit for gross proceeds of $1.75 million.
• The transaction includes significant insider participation (38.63% of units issued) and is accompanied by the settlement of certain debts through the issuance of common shares.
• Net proceeds are designated for general corporate purposes and working capital, while the company has also engaged Couloir Capital Ltd. for equity research coverage.

Key Details

• Private Placement Structure:
  • Units Issued: 8,750,000 units.
  • Price: $0.20 per unit.
  • Gross Proceeds: $1,750,000.
  • Components: Each unit consists of one common share and one-half of one common share purchase warrant.
  • Warrant Terms: Each warrant allows the purchase of one additional share at an exercise price of $0.45 per share for a period of two years from issuance.
  • Hold Period: All securities are subject to a hold period expiring on November 12, 2025.
  • Finders' Fees: Aggregate cash fees of $47,450 were paid.
  • Use of Proceeds: General corporate purposes and working capital.
  • Regulatory Status: Subject to final approval of the exchange.
• Insider Participation:
  • Insiders purchased 3,380,000 units, representing 38.63% of the units issued.
  • Associated common shares represent approximately 2.51% of issued common shares post-closing.
  • If warrants are exercised, insiders would hold approximately 3.72% of then-issued common shares.
  • Classified as a related party transaction under Multilateral Instrument 61-101; exemptions from formal valuation and minority shareholder approval were relied upon.
• Debt Settlement Update:
  • TSX Venture Exchange accepted the application to settle certain debts via the issuance of 221,972 common shares.
  • Deemed price per settlement share: $0.2034.
  • Shares issued on July 11, 2025, with a four-month hold period until November 12, 2025.
• Research Coverage:
  • Engaged Couloir Capital Ltd. for investor-focused equity research.
  • One-time fee of $45,000 for three research reports.
  • Reports disseminated via Bloomberg, FactSet, Capital IQ, LSEG, and other portals.

Notable Quotes

• "On behalf of the board of directors and the entire team at ReGen III, I would like to express my sincere gratitude to our shareholders -- both new and existing -- for their continued confidence and support. We are particularly encouraged by the strong participation from insiders, which reflects our team's deep conviction in ReGen III's proprietary technology, unique market opportunity and long-term potential," stated Tony Weatherill, chief executive officer and president. "We are committed to delivering results in 2025, and this investment positions us to advance our strategic priorities, including commercial arrangements, strategic partnerships and other opportunities that will accelerate our market entry."